Registration number:
DBA Applied BioSystems (UK) Ltd
for the Year Ended 31 January 2023
DBA Applied BioSystems (UK) Ltd
Contents
Company Information |
|
Director's Report |
|
Accountants' Report |
|
Balance Sheet |
|
Notes to the Financial Statements |
DBA Applied BioSystems (UK) Ltd
Company Information
Director |
Charlotte Mantor |
Registered office |
|
Accountants |
|
DBA Applied BioSystems (UK) Ltd
Director's Report for the Year Ended 31 January 2023
The director presents her report and the financial statements for the year ended 31 January 2023.
This report has been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and in accordance with FRS 105 The Financial Reporting Standard applicable to the Micro-entities Regime.
Directors of the company
The directors who held office during the year were as follows:
Small companies provision statement
This report has been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.
Approved and authorised by the
......................................... |
Chartered Accountants' Report to the Director on the Preparation of the Unaudited Statutory Accounts of
DBA Applied BioSystems (UK) Ltd
for the Year Ended 31 January 2023
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of DBA Applied BioSystems (UK) Ltd for the year ended 31 January 2023 as set out on pages 4 to 5 from the company's accounting records and from information and explanations you have given us.
As a practising member firm of the Chartered Institute of Management Accountants (CIMA), we are subject to its ethical and other professional requirements. These are based on the principles approved by IFAC.
This report is made solely to the Board of Directors of DBA Applied BioSystems (UK) Ltd, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the accounts of DBA Applied BioSystems (UK) Ltd and state those matters that we have agreed to state to the Board of Directors of DBA Applied BioSystems (UK) Ltd, as a body, in this report in accordance with the rules as laid down by CIMA. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than DBA Applied BioSystems (UK) Ltd and its Board of Directors as a body for our work or for this report.
DBA Applied BioSystems (UK) Ltd
(Registration number: 12393423)
Balance Sheet as at 31 January 2023
2023 |
2022 |
|
Fixed assets |
|
|
Current assets |
|
|
Prepayments and accrued income |
|
- |
Creditors: Amounts falling due within one year |
( |
( |
Net current assets |
|
|
Total assets less current liabilities |
|
|
Creditors: Amounts falling due after more than one year |
( |
( |
Accruals and deferred income |
( |
( |
( |
( |
|
Capital and reserves |
( |
( |
General information |
The company is a private company limited by share capital, incorporated in England.
The address of its registered office is:
These financial statements were authorised for issue by the
Basis of preparation
The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.
Staff numbers |
The average number of persons employed by the company (including the director) during the year, was
These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
Approved and authorised by the
DBA Applied BioSystems (UK) Ltd
(Registration number: 12393423)
Balance Sheet as at 31 January 2023
......................................... |